Chamas for Change: Impact of the COVID-19 Pandemic

NCT ID: NCT05787392

Last Updated: 2023-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

444 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-14

Study Completion Date

2025-03-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In Kenya, the chamas strategy (a peer support approach aimed at improving MNCH and reducing gender and social inequalities) has been shown to significantly improve maternal and child health outcomes while also providing social and financial support to participating women. However, the COVID-19 pandemic caused significant disruptions in women's work and MNCH services around the world due to reallocation of health care resources, COVID-19 fears, transportation restrictions, and lockdowns. These consequences appeared to disproportionately affect the poor, particularly poor women. The purpose of this participatory action design study is to determine how Chamas participation intersected with other factors to mitigate the effects of the COVID-19 pandemic on the health and economic well-being of women and children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study objectives are:

To evaluate the effect of Chama participation on mitigating the effects of the pandemic on social and gender equity.

* Impact on economic status (assessed using the changes in the Poverty Probability index scores)
* Impact on health service utilization and behaviours (assessed using enrollment in the national health insurance scheme, number of ANC visits attended, facility delivery, maternal death, newborn death, infant death, exclusive breastfeeding, number of children fully immunized at age 1)
* Social attitudes and well-being (assessed using, attitude towards harsh punishment of children, level of parental stress)
* COVID-19 related information (assessed using COVID-19 infection, COVID-19 vaccination, and effects of COVID restrictions)

To use an equity-centered design process and narrative approach to share research findings.

The research team intends to evaluate women's experiences during the pandemic using a mixed method approach and a participatory action design method. The focus will be on 3 study cohorts: (1) women who participated in Chamas throughout the pandemic, (2) women who left Chamas during the pandemic, (3) women whose communities were randomized to not receive the Chamas intervention. To better understand the effects of Chama participation on study outcomes, we will conduct an interviewer-administered survey among the described cohorts of women. This will be followed by qualitative studies to contextualize the study findings and investigate gender dynamics as social processes. Focus group discussions (FGDs) and key informant interviews (KIIs) will be conducted to further investigate our study cohort's experiences during the pandemic and identify strategies used by participants to mitigate the negative effects of the pandemic and its associated restrictions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gender Equity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Completed Chamas program

women who participated in Chamas throughout the pandemic

Chamas cha MamaToto program

Intervention Type BEHAVIORAL

Chamas is a community health volunteer (CHV)-led group programme that engages women during pregnancy and the first 1000 days of their child's life. The strategy focuses on promoting maternal, newborn, and child health (MNCH) by providing health education, peer support, and opportunities to access financial capital, all while addressing inequities that perpetuate poor outcomes.

Did not complete Chamas program

women who left Chamas during the pandemic

Chamas cha MamaToto program

Intervention Type BEHAVIORAL

Chamas is a community health volunteer (CHV)-led group programme that engages women during pregnancy and the first 1000 days of their child's life. The strategy focuses on promoting maternal, newborn, and child health (MNCH) by providing health education, peer support, and opportunities to access financial capital, all while addressing inequities that perpetuate poor outcomes.

Did not participate in Chamas program

women whose communities were randomized to not receive the Chamas intervention

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chamas cha MamaToto program

Chamas is a community health volunteer (CHV)-led group programme that engages women during pregnancy and the first 1000 days of their child's life. The strategy focuses on promoting maternal, newborn, and child health (MNCH) by providing health education, peer support, and opportunities to access financial capital, all while addressing inequities that perpetuate poor outcomes.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who participated in the 2021 Chamas study in Western Kenya

Exclusion Criteria

* Women who did not participate in the 2021 study.
Minimum Eligible Age

15 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

International Development Research Centre, Canada

OTHER_GOV

Sponsor Role collaborator

University of British Columbia

OTHER

Sponsor Role collaborator

Indiana University

OTHER

Sponsor Role collaborator

University of Toronto

OTHER

Sponsor Role collaborator

Moi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Astrid Christoffersen-Deb

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julia Songok

Role: PRINCIPAL_INVESTIGATOR

AMPATH Kenya

Sammy Masibo

Role: STUDY_DIRECTOR

Trans Nzoia county government

Michael Scanlon

Role: STUDY_DIRECTOR

Indiana University

Laura Ruhl

Role: STUDY_DIRECTOR

Indiana University

Julie Thorne

Role: STUDY_DIRECTOR

University of Toronto

Violet Naanyu

Role: STUDY_DIRECTOR

Moi University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Trans Nzoia county

Kiminini, , Kenya

Site Status

Trans-Nzoia County

Kitale, , Kenya

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Kenya

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MoiU7

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SMS Maama Project COVID-19
NCT04739462 COMPLETED NA
Game Changers for Family Planning Peer Advocacy Program
NCT06048328 NOT_YET_RECRUITING PHASE1/PHASE2